{"transactions":[{"id":1862568,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":112572,"kind":"person","name":"Quick Andrew","position":1,"cik":"0001817682","reported_name":"Quick Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2023-06-08T16:37:39.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These Stock Options vest in three equal annual installments beginning on the date 12 months following the grant date."}],"balance_after":60000,"derivative":{"exercise_price":14.17,"expiration_date":"2033-06-06","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-23-035439","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817682/000120919123035439/doc4.xml","form_type":"4"}},{"id":2212167,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":112572,"kind":"person","name":"Quick Andrew","position":1,"cik":"0001817682","reported_name":"Quick Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2022-07-06T18:54:49.000Z","date":"2022-07-01","kind":"grant","acquired":true,"shares":20650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These Stock Options vest in four equal annual installments beginning on August 20, 2023."}],"balance_after":20650,"derivative":{"exercise_price":4.97,"expiration_date":"2032-07-01","underlying":"Common Stock","underlying_shares":20650},"source":{"system":"sec-edgar","filing":"0001209191-22-041375","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1817682/000120919122041375/doc4.xml","form_type":"4"}},{"id":2212166,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":112572,"kind":"person","name":"Quick Andrew","position":1,"cik":"0001817682","reported_name":"Quick Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2022-07-06T18:54:49.000Z","date":"2022-07-01","kind":"grant","acquired":true,"shares":35950,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects Restricted Stock Units, each representing a contingent right to be issued one share of Common Stock. These Restricted Stock Units vest in four equal annual installments beginning on August 20, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested Restricted Stock Units."}],"balance_after":46450,"source":{"system":"sec-edgar","filing":"0001209191-22-041375","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817682/000120919122041375/doc4.xml","form_type":"4"}},{"id":2577453,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":112572,"kind":"person","name":"Quick Andrew","position":1,"cik":"0001817682","reported_name":"Quick Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-09-07T16:05:27.000Z","date":"2021-07-06","kind":"grant","acquired":true,"shares":6925,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These Stock Options vest in four equal annual installments upon the satisfaction of certain performance-based vesting criteria with respect to the\nparticular portion of such Stock Options."}],"balance_after":6925,"derivative":{"exercise_price":20.21,"expiration_date":"2031-07-06","underlying":"Common Stock","underlying_shares":6925},"source":{"system":"sec-edgar","filing":"0001209191-21-054954","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1817682/000120919121054954/doc4.xml","form_type":"4"}},{"id":2577452,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":112572,"kind":"person","name":"Quick Andrew","position":1,"cik":"0001817682","reported_name":"Quick Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-09-07T16:05:27.000Z","date":"2021-05-18","kind":"grant","acquired":true,"shares":4037,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These Stock Options were originally granted on May 18, 2017 and vested on May 18, 2021, upon the satisfaction of a performance-based vesting condition."}],"balance_after":20187,"derivative":{"exercise_price":6.32,"expiration_date":"2027-05-18","underlying":"Common Stock","underlying_shares":4037},"source":{"system":"sec-edgar","filing":"0001209191-21-054954","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1817682/000120919121054954/doc4.xml","form_type":"4"}},{"id":2577451,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":112572,"kind":"person","name":"Quick Andrew","position":1,"cik":"0001817682","reported_name":"Quick Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2021-09-07T16:05:27.000Z","date":"2021-07-06","kind":"grant","acquired":true,"shares":10500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects Restricted Stock Units, each representing a contingent right to be issued one share of Common Stock. These Restricted Stock Units vest in four equal annual installments upon the satisfaction of certain performance-vesting criteria with respect to the particular portion of Restricted Stock Units."}],"balance_after":10500,"source":{"system":"sec-edgar","filing":"0001209191-21-054954","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817682/000120919121054954/doc4.xml","form_type":"4"}},{"id":3033334,"issuer":{"id":5905,"kind":"organization","name":"AVITA Medical, Inc."},"owners":[{"id":112572,"kind":"person","name":"Quick Andrew","position":1,"cik":"0001817682","reported_name":"Quick Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2020-09-11T20:01:46.000Z","date":"2020-09-09","kind":"grant","acquired":true,"shares":4038,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These Stock Options were originally exercisable for ordinary shares of AVITA Medical, Ltd., an Australian public company and predecessor to the Issuer (\"Predecessor\"). Pursuant to a scheme of arrangement, completed on June 30, 2020 (the \"Scheme\"), the Stock Options became exercisable for shares of Common Stock of the Issuer in the ratio of one share of Common Stock for every 100 ordinary shares of Predecessor for which the Stock Options would otherwise have been exercisable."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The exercise price was converted from A$8.5, which reflects the 100:1 consolidation ratio applied in converting ordinary shares of Predecessor\nto shares of the Issuer's Common Stock, using the exchange rate as published by the Reserve Bank of Australia in effect on the date of grant\n(May 18, 2017). The actual exercise price will be the Australian dollar amount regardless of the exchange rate on the date of grant or of\nexercise."},{"field":"date","element":"transactionDate","label":"F3","text":"On September 9, 2020, the performance-based vesting condition with respect to these 4,038 Stock Options was satisfied."}],"balance_after":16150,"derivative":{"exercise_price":6.32,"exercise_date":"2020-09-09","expiration_date":"2027-05-18","underlying":"Common Stock","underlying_shares":4038},"source":{"system":"sec-edgar","filing":"0001209191-20-050218","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817682/000120919120050218/doc4.xml","form_type":"4"}}]}